ALNY

ALNYLAM PHARMACEUTICALS INC

Healthcare | Large Cap

$1.22

EPS Forecast

$1,132

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-08-16

Proximilar's AI forecasts

EPS Forecast:

$1.22

Revenue Forecast:

$1,132

EPS Surprise Forecast:

$0.191

Revenue Surprise Forecast:

$2

Post-release price volatility - High

Post-release Overnight Move:

±8.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

76%

Probability of beating revenue consensus:

54%

Probability of beating both EPS & revs consensus:

47%

Probability of missing both EPS & revs consensus:

17%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.85

Earnings volatility

EPS standard deviation:

$0.70

Revenue standard deviation:

$70

As % of share price:

0.22% MEDIUM

As % of market cap:

0.17% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$2.24

Revenue 95th %ile:

$1,237

EPS 75th %ile:

$1.49

Revenue 75th %ile:

$1,161

EPS 25th %ile:

$1.04

Revenue 25th %ile:

$1,107

EPS 5th %ile:

$0.57

Revenue 5th %ile:

$1,047

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

46% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

60% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$13

Bid-ask per Share:

$0.4